Endpoints News 2026년 4월 8일 Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application
Endpoints News 2026년 4월 7일 Terns sold to Merck for 13% lower than pharma's initial offer because of clinical data
Endpoints News 2026년 3월 25일 Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News 2026년 3월 24일 Merck partners with Flagship startup Quotient to search for genetic clues to IBD
Endpoints News 2025년 12월 18일 Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
Endpoints News 2025년 12월 5일 German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme